P01 Reclassifying cardiovascular risk using fat attenuation index (FAI) by CaRi-Heart® medical device in patients assessed with QRISK3 and CAD-RADS 2.0

IntroductionFat attenuation index (FAI) is a novel biomarker assessing coronary inflammation. In a non-UK population this inflammatory burden increased the relative risk of a fatal cardiac event. We describe risk reclassification by FAI versus QRISK3 (NICE recommended risk prediction tool) and the c...

Full description

Saved in:
Bibliographic Details
Published inHeart (British Cardiac Society) Vol. 109; no. Suppl 4; pp. A2 - A3
Main Authors Fulukwe, C, Murphy, D, Graby, J, Khavandi, A, Shirodaria, C, Antoniades, C, Rodrigues, JCL
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group LTD 01.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:IntroductionFat attenuation index (FAI) is a novel biomarker assessing coronary inflammation. In a non-UK population this inflammatory burden increased the relative risk of a fatal cardiac event. We describe risk reclassification by FAI versus QRISK3 (NICE recommended risk prediction tool) and the coronary artery disease reporting and data systems (CAD-RADS-2.0), the UK CTCA reporting standard.MethodsConsenting patients (ORFAN study) undergoing CTCA (Jan-2022 to April-2023) were included. QRISK3 <10% was classed as low-risk, 10-20% intermediate and ≥20% high-risk. A weighted FAI-score ≤75th percentile for the left anterior descending (LAD) or right coronary artery (RCA) and <95th for the left circumflex artery (Lcx) defined low-risk; 76-89th for LAD or RCA and ≥95th for Lcx defined high-risk; and ≥90th percentile for the LAD or RCA defined very high-risk.Results128 patients were included, mean age 61±8, 92 (72%) male. FAI re-classified 81% (36/44) of high-risk and 25% (5/20) of low-risk QRISK3 cases to low-risk and very high-risk respectively. Net reclassification -1.08. 20% (3/15) of CAD-RADS1 were very high-risk by FAI. A diagnostic odds ratio (DOR) for very high-risk (FAI) following CTCA was 1.8 (0.4-7.1;P=.4), 0.95 (0.3-2.7;P=.9), 0.5 (0.1-2;P=.3) and 1.3 (0.4-4;P=.7) for CAD-RADS 1-4 respectively and 0.6 (0.2-2.2;P=.4), 1.4 (0.4-4;P=.5), 1.2 (0.4-4;P=.8) and 0.7 (0.08-6;P=.8) for plaque grades 1-4 respectively. High-risk plaque had a DOR of 3.7 (1.2-10.8;P=.02).Conclusions25% of low-risk QRISK3 and 20% of CAD-RADS1 cases were reclassified as very high-risk following FAI analysis. High-risk plaque features were associated with very high-risk FAI, however CAD-RADS-2.0 severity grade was not.
ISSN:1355-6037
1468-201X
DOI:10.1136/heartjnl-2023-BSCI.5